Targeted therapy for NSCLC with driver mutations

Gabriele Minuti, Armida D'Incecco, Federico Cappuzzo
  • Expert Opinion on Biological Therapy, August 2013, Informa Healthcare
  • DOI: 10.1517/14712598.2013.827657

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Federico Cappuzzo